The Latest Breaking News from Alzheimer Disease

The UK’s drugs regulator – the MHRA – has approved the Alzheimer’s drug donanemab, but it won’t be available on the NHS.

Falling for financial scams may be an early indicator of Alzheimer's among older adults.

Donanemab is a so-called disease-modifying treatment.

Light pollution is a growing issue. Over the past 25 years, artificial lighting has surged by 49% worldwide. For perspective, the brightness of the night sky has risen by almost 10% per year over the last 12 years. Around 80% of the global population is now affected by light pollution.

Alzheimer's can be passed down from parents to children, but new research reveals whether a particular parent is more likely to be responsible.

Excessive light pollution increases the risk of Alzheimer's in both older and younger adults. For those under 65, nighttime light exposure poses a greater risk of developing Alzheimer's disease compared to many other known factors.

A letter citing 10 studies, published by the American Journal of the Medical Sciences, says picking your nose could increase risk of dementia

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower risk of dementia.

Lecanemab has been deamed too expensive for use on the NHS.